{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:47:13Z","timestamp":1792079233109,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12010-026-05901-9","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:10:13Z","timestamp":1789197013000},"page":"9360-9402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design of Multi-Epitope Cancer Vaccine Targeting p53 Tumor Antigen using Myotis lucifugus Sequencers: An Immunoinformatics Approach"],"prefix":"10.1007","volume":"198","author":[{"given":"Bhavin","family":"Maru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0817-5940","authenticated-orcid":false,"given":"Ashish","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya Nath","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"issue":"7","key":"5901_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira, S., & Takeda, K. (2004). Toll-like receptor signalling. Nature Reviews Immunology, 4(7), 499\u2013511. https:\/\/doi.org\/10.1038\/nri1391","journal-title":"Nature Reviews Immunology"},{"issue":"4","key":"5901_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira, S., Uematsu, S., & Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell, 124(4), 783\u2013801. https:\/\/doi.org\/10.1016\/j.cell.2006.02.015","journal-title":"Cell"},{"issue":"4","key":"5901_CR3","first-page":"1284","volume":"9","author":"PJ Bergman","year":"2003","unstructured":"Bergman, P. J., McKnight, J., Novosad, A., Charney, S., Farrelly, J., Craft, D., Wulderk, M., Jeffers, Y., Sadelain, M., Hohenhaus, A. E., Segal, N., Gregor, P., Engelhorn, M., Riviere, I., Houghton, A. N., & Wolchok, J. D. (2003). Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: A phase I trial. Clinical Cancer Research, 9(4), 1284\u20131290.","journal-title":"Clinical Cancer Research"},{"issue":"5595","key":"5901_CR4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1126\/science.1075565","volume":"298","author":"A Biragyn","year":"2002","unstructured":"Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. J., & Kwak, L. W. (2002). Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science, 298(5595), 1025\u20131029. https:\/\/doi.org\/10.1126\/science.1075565","journal-title":"Science"},{"issue":"2","key":"5901_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc.2017.109","volume":"18","author":"VJN Bykov","year":"2018","unstructured":"Bykov, V. J. N., Eriksson, S. E., Bianchi, J., & Wiman, K. G. (2018). Targeting mutant p53 for efficient cancer therapy. Nature Reviews Cancer, 18(2), 89\u2013102. https:\/\/doi.org\/10.1038\/nrc.2017.109","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"5901_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen, D. S., & Mellman, I. (2013). Oncology meets immunology: The cancer-immunity cycle. Immunity, 39(1), 1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012","journal-title":"Immunity"},{"issue":"10","key":"5901_CR7","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen, X., Zaro, J. L., & Shen, W. C. (2013). Fusion protein linkers: Property, design and functionality. Advanced Drug Delivery Reviews, 65(10), 1357\u20131369. https:\/\/doi.org\/10.1016\/j.addr.2012.09.039","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"5170","key":"5901_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1126\/science.8023157","volume":"265","author":"Y Cho","year":"1994","unstructured":"Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science, 265(5170), 346\u2013355. https:\/\/doi.org\/10.1126\/science.8023157","journal-title":"Science"},{"issue":"1\u20132","key":"5901_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0022-1759(01)00535-x","volume":"260","author":"JR Currier","year":"2002","unstructured":"Currier, J. R., Kuta, E. G., Turk, E., Earhart, L. B., Loomis-Price, L., Janetzki, S., Ferrari, G., Birx, D. L., & Cox, J. H. (2002). A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. Journal Of Immunological Methods, 260(1\u20132), 157\u2013172. https:\/\/doi.org\/10.1016\/s0022-1759(01)00535-x","journal-title":"Journal Of Immunological Methods"},{"issue":"9","key":"5901_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.str.2020.06.006","volume":"28","author":"IT Desta","year":"2020","unstructured":"Desta, I. T., Porter, K. A., Xia, B., Kozakov, D., & Vajda, S. (2020). Performance and its limits in rigid body protein-protein docking. Structure, 28(9), 1071-1081e.e1073. https:\/\/doi.org\/10.1016\/j.str.2020.06.006","journal-title":"Structure"},{"key":"5901_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01369","volume":"9","author":"SK Dhanda","year":"2018","unstructured":"Dhanda, S. K., Karosiene, E., Edwards, L., Grifoni, A., Paul, S., Andreatta, M., Weiskopf, D., Sidney, J., Nielsen, M., Peters, B., & Sette, A. (2018). Predicting HLA CD4 immunogenicity in human populations. Frontiers in Immunology, 9, Article 1369. https:\/\/doi.org\/10.3389\/fimmu.2018.01369","journal-title":"Frontiers in Immunology"},{"issue":"W1","key":"5901_CR12","doi-asserted-by":"publisher","first-page":"W502","DOI":"10.1093\/nar\/gkz452","volume":"47","author":"SK Dhanda","year":"2019","unstructured":"Dhanda, S. K., Mahajan, S., Paul, S., Yan, Z., Kim, H., Jespersen, M. C., Jurtz, V., Andreatta, M., Greenbaum, J. A., Marcatili, P., Sette, A., Nielsen, M., & Peters, B. (2019). IEDB-AR: Immune epitope database-analysis resource in 2019. Nucleic Acids Research, 47(W1), W502\u2013w506. https:\/\/doi.org\/10.1093\/nar\/gkz452","journal-title":"Nucleic Acids Research"},{"issue":"12","key":"5901_CR13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1101\/gad.190678.112","volume":"26","author":"WA Freed-Pastor","year":"2012","unstructured":"Freed-Pastor, W. A., & Prives, C. (2012). Mutant p53: One name, many proteins. Genes & Development, 26(12), 1268\u20131286. https:\/\/doi.org\/10.1101\/gad.190678.112","journal-title":"Genes & Development"},{"issue":"10","key":"5901_CR14","first-page":"2963","volume":"5","author":"DI Gabrilovich","year":"1999","unstructured":"Gabrilovich, D. I., Ishida, T., Nadaf, S., Ohm, J. E., & Carbone, D. P. (1999). Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clinical Cancer Research, 5(10), 2963\u20132970.","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"5901_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon, J., & Bruni, D. (2019). Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nature Reviews. Drug Discovery, 18(3), 197\u2013218. https:\/\/doi.org\/10.1038\/s41573-018-0007-y","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"10","key":"5901_CR16","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., Wang, E., Douek, D. C., Price, D. A., June, C. H., Marincola, F. M., Roederer, M., & Restifo, N. P. (2011). A human memory T cell subset with stem cell-like properties. Nature Medicine, 17(10), 1290\u20131297. https:\/\/doi.org\/10.1038\/nm.2446","journal-title":"Nature Medicine"},{"key":"5901_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-0716-3874-3_2","volume":"2809","author":"FF Gonzalez-Galarza","year":"2024","unstructured":"Gonzalez-Galarza, F. F., McCabe, A., Melo Dos Santos, E. J., Ghattaoraya, G., Jones, A. R., & Middleton, D. (2024). Allele Frequency Net Database. Methods In Molecular Biology, 2809, 19\u201336. https:\/\/doi.org\/10.1007\/978-1-0716-3874-3_2","journal-title":"Methods In Molecular Biology"},{"issue":"6","key":"5901_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","volume":"63","author":"J Greenbaum","year":"2011","unstructured":"Greenbaum, J., Sidney, J., Chung, J., Brander, C., Peters, B., & Sette, A. (2011). Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics, 63(6), 325\u2013335. https:\/\/doi.org\/10.1007\/s00251-011-0513-0","journal-title":"Immunogenetics"},{"issue":"3","key":"5901_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1172\/jci19418","volume":"113","author":"DA Gross","year":"2004","unstructured":"Gross, D. A., Graff-Dubois, S., Opolon, P., Cornet, S., Alves, P., Bennaceur-Griscelli, A., Faure, O., Guillaume, P., Firat, H., Chouaib, S., Lemonnier, F. A., Davoust, J., Miconnet, I., Vonderheide, R. H., & Kosmatopoulos, K. (2004). High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy. J Clin Invest, 113(3), 425\u2013433. https:\/\/doi.org\/10.1172\/jci19418","journal-title":"J Clin Invest"},{"issue":"2","key":"5901_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/protein\/4.2.155","volume":"4","author":"K Guruprasad","year":"1990","unstructured":"Guruprasad, K., Reddy, B. V., & Pandit, M. W. (1990). Correlation between stability of a protein and its dipeptide composition: A novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Engineering, 4(2), 155\u2013161. https:\/\/doi.org\/10.1093\/protein\/4.2.155","journal-title":"Protein Engineering"},{"issue":"11","key":"5901_CR21","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1110\/ps.062405906","volume":"15","author":"P Haste Andersen","year":"2006","unstructured":"Haste Andersen, P., Nielsen, M., & Lund, O. (2006). Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Science, 15(11), 2558\u20132567. https:\/\/doi.org\/10.1110\/ps.062405906","journal-title":"Protein Science"},{"issue":"6630","key":"5901_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y Haupt","year":"1997","unstructured":"Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature, 387(6630), 296\u2013299. https:\/\/doi.org\/10.1038\/387296a0","journal-title":"Nature"},{"issue":"3","key":"5901_CR23","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1084\/jem.20171440","volume":"215","author":"S Hoves","year":"2018","unstructured":"Hoves, S., Ooi, C. H., Wolter, C., Sade, H., Bissinger, S., Schmittnaegel, M., Ast, O., Giusti, A. M., Wartha, K., Runza, V., Xu, W., Kienast, Y., Cannarile, M. A., Levitsky, H., Romagnoli, S., De Palma, M., R\u00fcttinger, D., & Ries, C. H. (2018). Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity. Journal of Experimental Medicine, 215(3), 859\u2013876. https:\/\/doi.org\/10.1084\/jem.20171440","journal-title":"Journal of Experimental Medicine"},{"key":"5901_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","volume":"77","author":"AC Joerger","year":"2008","unstructured":"Joerger, A. C., & Fersht, A. R. (2008). Structural biology of the tumor suppressor p53. Annual Review Of Biochemistry, 77, 557\u2013582. https:\/\/doi.org\/10.1146\/annurev.biochem.77.060806.091238","journal-title":"Annual Review Of Biochemistry"},{"issue":"5","key":"5901_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai, T., & Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nature Immunology, 11(5), 373\u2013384. https:\/\/doi.org\/10.1038\/ni.1863","journal-title":"Nature Immunology"},{"issue":"1","key":"5901_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.immuni.2004.12.005","volume":"22","author":"J Kuball","year":"2005","unstructured":"Kuball, J., Schmitz, F. W., Voss, R. H., Ferreira, E. A., Engel, R., Guillaume, P., Strand, S., Romero, P., Huber, C., Sherman, L. A., & Theobald, M. (2005). Cooperation of human tumor-reactive CD4\u2009+\u2009and CD8\u2009+\u2009T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity, 22(1), 117\u2013129. https:\/\/doi.org\/10.1016\/j.immuni.2004.12.005","journal-title":"Immunity"},{"issue":"1","key":"5901_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte, J., & Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. Journal Of Molecular Biology, 157(1), 105\u2013132. https:\/\/doi.org\/10.1016\/0022-2836(82)90515-0","journal-title":"Journal Of Molecular Biology"},{"issue":"9","key":"5901_CR28","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/ijc.24597","volume":"125","author":"N Leffers","year":"2009","unstructured":"Leffers, N., Lambeck, A. J., Gooden, M. J., Hoogeboom, B. N., Wolf, R., Hamming, I. E., Hepkema, B. G., Willemse, P. H., Molmans, B. H., Hollema, H., Drijfhout, J. W., Sluiter, W. J., Valentijn, A. R., Fathers, L. M., Oostendorp, J., van der Zee, A. G., Melief, C. J., van der Burg, S. H., Daemen, T., & Nijman, H. W. (2009). Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial. International Journal Of Cancer, 125(9), 2104\u20132113. https:\/\/doi.org\/10.1002\/ijc.24597","journal-title":"International Journal Of Cancer"},{"issue":"10","key":"5901_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine, A. J., & Oren, M. (2009). The first 30 years of p53: Growing ever more complex. Nature Reviews Cancer, 9(10), 749\u2013758. https:\/\/doi.org\/10.1038\/nrc2723","journal-title":"Nature Reviews Cancer"},{"key":"5901_CR30","first-page":"8","volume":"6","author":"JC Liao","year":"2006","unstructured":"Liao, J. C., Gregor, P., Wolchok, J. D., Orlandi, F., Craft, D., Leung, C., Houghton, A. N., & Bergman, P. J. (2006). Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma. Cancer Immunity, 6, 8.","journal-title":"Cancer Immunity"},{"issue":"3","key":"5901_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrc1815","volume":"6","author":"PL Lollini","year":"2006","unstructured":"Lollini, P. L., Cavallo, F., Nanni, P., & Forni, G. (2006). Vaccines for tumour prevention. Nature Reviews Cancer, 6(3), 204\u2013216. https:\/\/doi.org\/10.1038\/nrc1815","journal-title":"Nature Reviews Cancer"},{"issue":"13","key":"5901_CR32","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.2174\/138945011798184146","volume":"12","author":"PL Lollini","year":"2011","unstructured":"Lollini, P. L., Nicoletti, G., Landuzzi, L., Cavallo, F., Forni, G., De Giovanni, C., & Nanni, P. (2011). Vaccines and other immunological approaches for cancer immunoprevention. Current Drug Targets, 12(13), 1957\u20131973. https:\/\/doi.org\/10.2174\/138945011798184146","journal-title":"Current Drug Targets"},{"issue":"7378","key":"5901_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman, I., Coukos, G., & Dranoff, G. (2011). Cancer immunotherapy comes of age. Nature, 480(7378), 480\u2013489. https:\/\/doi.org\/10.1038\/nature10673","journal-title":"Nature"},{"issue":"3","key":"5901_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","volume":"25","author":"PA Muller","year":"2014","unstructured":"Muller, P. A., & Vousden, K. H. (2014). Mutant p53 in cancer: New functions and therapeutic opportunities. Cancer Cell, 25(3), 304\u2013317. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.021","journal-title":"Cancer Cell"},{"key":"5901_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","volume":"349","author":"N Nezafat","year":"2014","unstructured":"Nezafat, N., Ghasemi, Y., Javadi, G., Khoshnoud, M. J., & Omidinia, E. (2014). A novel multi-epitope peptide vaccine against cancer: An in silico approach. Journal Of Theoretical Biology, 349, 121\u2013134. https:\/\/doi.org\/10.1016\/j.jtbi.2014.01.018","journal-title":"Journal Of Theoretical Biology"},{"issue":"5","key":"5901_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen, M., Lundegaard, C., Worning, P., Lauem\u00f8ller, S. L., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2003). Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Science, 12(5), 1007\u20131017. https:\/\/doi.org\/10.1110\/ps.0239403","journal-title":"Protein Science"},{"issue":"1","key":"5901_CR37","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier, M., Hollstein, M., & Hainaut, P. (2010). TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harbor Perspectives in Biology, 2(1), a001008. https:\/\/doi.org\/10.1101\/cshperspect.a001008","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"4","key":"5901_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20030590","volume":"198","author":"WW Overwijk","year":"2003","unstructured":"Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., Heimann, D. M., Klebanoff, C. A., Yu, Z., Hwang, L. N., Feigenbaum, L., Kruisbeek, A. M., Rosenberg, S. A., & Restifo, N. P. (2003). Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8 + T cells. Journal of Experimental Medicine, 198(4), 569\u2013580. https:\/\/doi.org\/10.1084\/jem.20030590","journal-title":"Journal of Experimental Medicine"},{"issue":"8","key":"5901_CR39","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1158\/1078-0432.Ccr-06-2353","volume":"13","author":"C Palena","year":"2007","unstructured":"Palena, C., Polev, D. E., Tsang, K. Y., Fernando, R. I., Litzinger, M., Krukovskaya, L. L., Baranova, A. V., Kozlov, A. P., & Schlom, J. (2007). The human T-box mesodermal transcription factor brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clinical Cancer Research, 13(8), 2471\u20132478. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-2353","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"5901_CR40","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.120139","volume":"3","author":"A Patronov","year":"2013","unstructured":"Patronov, A., & Doytchinova, I. (2013). T-cell epitope vaccine design by immunoinformatics. Open Biology, 3(1), Article 120139. https:\/\/doi.org\/10.1098\/rsob.120139","journal-title":"Open Biology"},{"issue":"4","key":"5901_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.bjc.6602019","volume":"91","author":"M Pavlenko","year":"2004","unstructured":"Pavlenko, M., Roos, A. K., Lundqvist, A., Palmborg, A., Miller, A. M., Ozenci, V., Bergman, B., Egevad, L., Hellstr\u00f6m, M., Kiessling, R., Masucci, G., Wers\u00e4ll, P., Nilsson, S., & Pisa, P. (2004). A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. British Journal of Cancer, 91(4), 688\u2013694. https:\/\/doi.org\/10.1038\/sj.bjc.6602019","journal-title":"British Journal of Cancer"},{"key":"5901_CR42","doi-asserted-by":"publisher","DOI":"10.1530\/jme-24-0143","author":"ML Price","year":"2025","unstructured":"Price, M. L., Wyatt, R. A., Correia, J., Areej, Z., Hinds, M., Crastin, A., Hardy, R. S., Frost, M., & Gorvin, C. M. (2025). Identification of anti-resorptive GPCRs by high-content imaging in human osteoclasts. Journal of Molecular Endocrinology. https:\/\/doi.org\/10.1530\/jme-24-0143","journal-title":"Journal of Molecular Endocrinology"},{"key":"5901_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1479-5876-12-55","volume":"12","author":"OE Rahma","year":"2014","unstructured":"Rahma, O. E., Hamilton, J. M., Wojtowicz, M., Dakheel, O., Bernstein, S., Liewehr, D. J., Steinberg, S. M., & Khleif, S. N. (2014). The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors. J Transl Med, 12, 55. https:\/\/doi.org\/10.1186\/1479-5876-12-55","journal-title":"J Transl Med"},{"issue":"W1","key":"5901_CR44","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M. (2020). NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Research, 48(W1), W449\u2013w454. https:\/\/doi.org\/10.1093\/nar\/gkaa379","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"5901_CR45","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/1947601911408889","volume":"2","author":"N Rivlin","year":"2011","unstructured":"Rivlin, N., Brosh, R., Oren, M., & Rotter, V. (2011). Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer, 2(4), 466\u2013474. https:\/\/doi.org\/10.1177\/1947601911408889","journal-title":"Genes Cancer"},{"issue":"9","key":"5901_CR46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm1100","volume":"10","author":"SA Rosenberg","year":"2004","unstructured":"Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004). Cancer immunotherapy: Moving beyond current vaccines. Nature Medicine, 10(9), 909\u2013915. https:\/\/doi.org\/10.1038\/nm1100","journal-title":"Nature Medicine"},{"issue":"6382","key":"5901_CR47","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.aar7112","volume":"359","author":"U Sahin","year":"2018","unstructured":"Sahin, U., & T\u00fcreci, \u00d6. (2018). Personalized vaccines for cancer immunotherapy. Science, 359(6382), 1355\u20131360. https:\/\/doi.org\/10.1126\/science.aar7112","journal-title":"Science"},{"issue":"8","key":"5901_CR48","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djs033","volume":"104","author":"J Schlom","year":"2012","unstructured":"Schlom, J. (2012). Therapeutic cancer vaccines: Current status and moving forward. Journal Of The National Cancer Institute, 104(8), 599\u2013613. https:\/\/doi.org\/10.1093\/jnci\/djs033","journal-title":"Journal Of The National Cancer Institute"},{"issue":"7","key":"5901_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41568-018-0004-9","volume":"18","author":"A Seluanov","year":"2018","unstructured":"Seluanov, A., Gladyshev, V. N., Vijg, J., & Gorbunova, V. (2018). Mechanisms of cancer resistance in long-lived mammals. Nature Reviews Cancer, 18(7), 433\u2013441. https:\/\/doi.org\/10.1038\/s41568-018-0004-9","journal-title":"Nature Reviews Cancer"},{"issue":"4","key":"5901_CR50","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","volume":"33","author":"A Sette","year":"2010","unstructured":"Sette, A., & Rappuoli, R. (2010). Reverse vaccinology: Developing vaccines in the era of genomics. Immunity, 33(4), 530\u2013541. https:\/\/doi.org\/10.1016\/j.immuni.2010.09.017","journal-title":"Immunity"},{"issue":"1","key":"5901_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1803s100","volume":"100","author":"J Sidney","year":"2013","unstructured":"Sidney, J., Southwood, S., Moore, C., Oseroff, C., Pinilla, C., Grey, H. M., & Sette, A. (2013). Measurement of MHC\/peptide interactions by gel filtration or monoclonal antibody capture. Current Protocols in Immunology, , Article Unit 18.13. https:\/\/doi.org\/10.1002\/0471142735.im1803s100","journal-title":"Current Protocols in Immunology"},{"issue":"1","key":"5901_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"5901_CR53","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1158\/1078-0432.Ccr-08-2227","volume":"15","author":"FM Speetjens","year":"2009","unstructured":"Speetjens, F. M., Kuppen, P. J., Welters, M. J., Essahsah, F., van den Voet, A. M., Lantrua, M. G., Valentijn, A. R., Oostendorp, J., Fathers, L. M., Nijman, H. W., Drijfhout, J. W., van de Velde, C. J., Melief, C. J., & van der Burg, S. H. (2009). Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer. Clinical Cancer Research, 15(3), 1086\u20131095. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-2227","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"5901_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. C Ca: A Cancer Journal For Clinicians, 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"C Ca: A Cancer Journal For Clinicians"},{"issue":"7","key":"5901_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00262-003-0493-5","volume":"53","author":"IM Svane","year":"2004","unstructured":"Svane, I. M., Pedersen, A. E., Johnsen, H. E., Nielsen, D., Kamby, C., Gaarsdal, E., Nikolajsen, K., Buus, S., & Claesson, M. H. (2004). Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: Report from a phase I study. Cancer Immunology, Immunotherapy, 53(7), 633\u2013641. https:\/\/doi.org\/10.1007\/s00262-003-0493-5","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"1","key":"5901_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100361","volume":"7","author":"J Tobias","year":"2022","unstructured":"Tobias, J., Garner-Spitzer, E., Drini\u0107, M., & Wiedermann, U. (2022). Vaccination against Her-2\/neu, with focus on peptide-based vaccines. ESMO Open, 7(1), Article 100361. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100361","journal-title":"ESMO Open"},{"issue":"1","key":"5901_CR57","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/jco.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso, J. F., Gill, V. J., Hwu, P., Marincola, F. M., Restifo, N. P., Schwartzentruber, D. J., Sherry, R. M., Topalian, S. L., Yang, J. C., Stock, F., Freezer, L. J., Morton, K. E., Seipp, C., Haworth, L., Mavroukakis, S., White, D., MacDonald, S., Mao, J., Sznol, M., & Rosenberg, S. A. (2002). Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. Journal Of Clinical Oncology, 20(1), 142\u2013152. https:\/\/doi.org\/10.1200\/jco.2002.20.1.142","journal-title":"Journal Of Clinical Oncology"},{"issue":"D1","key":"5901_CR58","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2019","unstructured":"Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2019). The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Research, 47(D1), D339\u2013d343. https:\/\/doi.org\/10.1093\/nar\/gky1006","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"5901_CR59","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden, K. H., & Lane, D. P. (2007). p53 in health and disease. Nature Reviews Molecular Cell Biology, 8(4), 275\u2013283. https:\/\/doi.org\/10.1038\/nrm2147","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"5439","key":"5901_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.286.5439.525","volume":"286","author":"D Yang","year":"1999","unstructured":"Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schr\u00f6der, J. M., Wang, J. M., Howard, O. M., & Oppenheim, J. J. (1999). Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science, 286(5439), 525\u2013528. https:\/\/doi.org\/10.1126\/science.286.5439.525","journal-title":"Science"},{"issue":"6118","key":"5901_CR61","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1230835","volume":"339","author":"G Zhang","year":"2013","unstructured":"Zhang, G., Cowled, C., Shi, Z., Huang, Z., Bishop-Lilly, K. A., Fang, X., Wynne, J. W., Xiong, Z., Baker, M. L., Zhao, W., Tachedjian, M., Zhu, Y., Zhou, P., Jiang, X., Ng, J., Yang, L., Wu, L., Xiao, J., Feng, Y., \u2026 Wang, J. (2013). Comparative analysis of bat genomes provides insight into the evolution of flight and immunity. Science, 339(6118), 456\u2013460. https:\/\/doi.org\/10.1126\/science.1230835","journal-title":"Science"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05901-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:16:19Z","timestamp":1792077379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05901-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5901"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05901-9","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"24 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author declares no competing interest.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}